FDA Flags Major Sanitation, Record-Keeping Falsification At Dabur India Plant
Photo: Wikimedia
India-West News Desk
NEW DELHI – US regulators have cited serious manufacturing and sanitation violations at a production facility in Dadra and Nagar Haveli operated by Dabur India, according to an inspection report released this week, raising new concerns over compliance standards at one of India’s best-known makers of health and personal care products.
The inspection carries particular significance in the United States, where Dabur markets a range of over-the-counter healthcare products, including antifungal treatments, pain relief gels, vapor rubs, and oral care items sold through mainstream retail and online channels.
The findings stem from a January inspection by the U.S. Food and Drug Administration, which documented multiple deficiencies at the plant, including falsification of manufacturing records, quality controls, and conditions that inspectors said could create contamination risks.
According to the FDA report, investigators found evidence that production records had been altered to obscure how certain equipment was being used, with machinery assigned to specific products reportedly used across multiple manufacturing processes. The agency also said company officials did not adequately review production and quality documentation before batches were approved for release.
FDA inspectors also noted sanitation issues inside warehouse areas tied to the facility. The report said a live bird and bird droppings were found in a raw material storage area near packaging supplies. Investigators additionally observed dark unidentified residue covering large portions of ceiling surfaces in both raw material and finished goods warehouses.
The agency also questioned the reliability of microbiological testing performed at the site. Additional observations cited weaknesses in equipment cleaning and maintenance procedures.
Read the latest business news today including market trends, startups, economy, finance, technology, and corporate updates followed by readers and professionals across Canada.
Vijay
/
Unfortunately, these peopel are still sleeping at switch. They are not in habit of taking FDA’s requirements seriously.
May 29, 2026Natarajan Sivsubramanian
/
Dabur s products should be banned until they correct the condition
FDA should order removal of all imported products from India Dabur from the shelves of all Indian
May 29, 2026Retail and whole sale groceries
JAYANANDA HIRANANDANI
/
Public sector units have been regarded as having poor management. This is an example where a private sector unit is having poor management. For both of the sectors, the work psychology is deficient. Look at the car accidents. The change has to come in the individual workers and the management.
Quality contral has some interesting aspects. It is very much to do with the man, and NOT witht the machine!
Firstly, does the worker lnow what he/she is ACTUALY doing?
May 29, 2026Secondly, does he/she know what is supposed to be done to make the product or service right.?
Thirdly, does he /she have the will and determination to what is right?
Fourthly, does he have the support and co-operation of management to do what is right?